EvaluatePharma - Takeda - Worldwide

EvaluatePharma® - the premier source for pharma and biotech analysis.

Expert integration of financial and product data across historic and forecast timeframes (1986 to 2016) delivers a vast array of analytics by product, company, therapy area, EphMRA ATC code, technology, patent status, deals, license revenues and much more.

Company Profile



Profile	Takeda Pharmaceutical Company is an Osaka, Japan, based pharmaceutical company. Operates in the US through Takeda Pharmaceuticals North America (TPNA).
Listed or Private Company	Listed
Company Classification	Regional Major
Company Website	Website

Full Company Profile Information

EventAnalyzer - Last Key Event


Closing Price DateClosing Price Date	EventAnalyzer Note	Market Cap (US $m)	Change (%)	Change (+$m)
8/27/2010	27 Aug: The FDA releases its latest list of possible drug safety concerns, which includes the company's gout management drug, Uloric.	33,470	-0.6%	-218

Top 3 Products (Worldwide Sales 2007/08)

				Annual Sales WW - Sales		Growth per Year (%)
Rank¹	Product	Generic Name	Therapeutic Subcategory	2007	2008	2008
1	Actos	pioglitazone hydrochloride	Anti-diabetics	3,480	3,865	+11%
2	Prevacid/Takepron	lansoprazole	Antacids & anti-ulcerants	569²	2,435³	+328%
3	Blopress	candesartan cilexetil	Angiotensin II antagonists	1,204	1,377	+14%

Note: Shaded Cells⁴

RX Sales Chart

Takeda	Data		Growth
	2007	2008	2008
Revenues By Segment
Pharmaceuticals
Pharmaceuticals Sales (In-depth)
Rx & OTC Pharmaceuticals
Prescription (Rx) Pharmaceuticals	9,737⁵	11,900⁶	+22%

Therapy Area Focus in 2008

Takeda
	2008
WW Rx & OTC Sales By Therapy Area
Main Categories
Blood	0
Cardiovascular	1,424
Central Nervous System	132
Endocrine	4,416
Gastro-Intestinal	3,037
Musculoskeletal	709
Oncology & Immunomodulators	1,112
Respiratory	93
Systemic Anti-Infectives	308
Other Rx & OTC Pharma	1,313⁷

EvaluatePharma® Coverage of Marketed and Pipeline Products


	Product Count
Takeda ⁸	226

2009 Product Sales analysis
2009 Pharmaceutical Sales
2009 Market Share & Global Ranking
Download to Excel
Search 2 yrs of company press releases


EP Vantage - last 6 months

Obesity race tightens up as Takeda snares Contrave (September 02, 2010)

First half 2010 sees a return to more conventional deal values (July 28, 2010)

Therapeutic focus - Avandia's decline and the type 2 diabetes market (July 15, 2010)

Will FDA pass the buck on key Avandia decision? (July 15, 2010)

Pharma industry cutting its R&D cloth to more sustainable levels (July 07, 2010)

Displaying 5 out of a possible 14 unique stories.
Results Sorted By date
Display All Stories

Ranked on:
Annual Sales WW
2008

Group Total: Equals the sum of values in report based on report grouping.

Note: Where Top 5,10,100 etc filters have been applied, the aggregate value relates to the total of the original unfiltered group - not the displayed filtered data. Where n/a appears, a value has been hidden but is included in Group Total.

Examples:

e.g. Top 100 drugs reports. These are not grouped but are filtered to show only the top 100 products by sales in a particular year. The Group Total displayed is equal to the sum of all data within Evaluate Pharma - not just the top 100 products i.e. total market size.

e.g. Global Majors - Top 10 products. Report is grouped by Company and filtered to show only the top 10 products by sales in a particular year. Group Totals are displayed for each company and are equal to the sum of all available data for that company - not just the top 10 products.

XXXXXXXXXXXXXX XXXXXXX:

XXXXXXXX XX XXX XX XX XXX (XXXXX XXXXXXX XXXX XXXXXX).

XXXXXXXXXXXXXX® XXXXXXX:
XXXXX XXXXXXX XX XXXXX XXXX X XXX XXXX XX XX XXXXX XXXX.

XXXXX XX X XXX XXXX XXXXXXXX XXX XXXXXXXX XX XXX XX XX XXX, X XXXXX XXXXXXX XXXXXXX XXXXXX XXX XXXXXX.

XX X XXX XXXX XXXXXX XXX XXXXXX XXXXXXXXX XXX XXX XXXXX XXXXXXX XXX XXXXXX XXXXXXX XXXXXXXXX XXXXXXXX XXXXXXXX XX XXX XX.

XXXXXXXX XX ¥XX:
X) +XX.X XXXXX
X) +XXX.X XXXXXXXX

Shaded Cells

A shaded cell signifies potentially incomplete data. E.g. A shaded cell in "Change (+/-)" means there is no corresponding value, i.e. there is data for 2001, but no data for 2000. This could signify a product launch, first time disclosure of sales, a product acquisition or missing data.

A shaded cell containing n/a signifies valid data followed by blank or zero values. E.g. A shaded cell containing n/a in "Change (+/-)" means a value is present for 2000, but blank for 2001. This could signify a product disposal / withdrawal, discontinuation of disclosure or missing data.

XXXXXXXX XX ¥X:
X) +XXXXXXX XXXXXXX XXXXX.
X) +XXXXXX XX% XXXXX XX XXX XX XXXXX.
XXXX
X) +XXXXX XXXXXXXXX.
X) +XXXXXX XXXX XXXXXX XXXXXXXX.

XXXXXXXXXXXXXX XXXXXXX:
XXXXXXXX XX% XX XXX XXXXXXXXXXXXXX XXXXXXXX XX XX XX X XXX XXXX XXXX XX XXX XXXXXXXXX.